LATITUDE Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- LATITUDE Pharmaceuticals's estimated annual revenue is currently $7.8M per year.
- LATITUDE Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- LATITUDE Pharmaceuticals has 39 Employees.
- LATITUDE Pharmaceuticals grew their employee count by 8% last year.
LATITUDE Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Business Development | Reveal Email/Phone |
2 | Director Quality | Reveal Email/Phone |
3 | Director | Reveal Email/Phone |
4 | Manager, Formulations R&D | Reveal Email/Phone |
LATITUDE Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is LATITUDE Pharmaceuticals?
LATITUDE Pharmaceuticals is a leading-edge contract research boutique that provides innovative drug formulation services to the biotech and pharmaceutical industries with expertise in formulating insoluble, unstable, and other problematic drug molecules. We focus our expertise, acquired from years of experience, to develop leading-edge formulations and intellectual property for our clients. In addition to its contract research services, our internal reformulation programs are actively creating out license-ready 505(b)(2) NDA opportunities through innovative formulations.
keywords:N/AN/A
Total Funding
39
Number of Employees
$7.8M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.4M | 39 | 11% | N/A |
#2 | $4.4M | 39 | N/A | N/A |
#3 | $4.4M | 39 | -20% | N/A |
#4 | $8.4M | 39 | 8% | N/A |
#5 | $8.4M | 39 | 11% | N/A |